In this episode of From Science to Strategy, we explore the dark genome – once considered junk but now emerging as pharma’s next billion-dollar bet in therapeutics. We’ll dive into how this overlooked part of our DNA is reshaping drug discovery, improving cancer and diabetes treatments, and why it's attracting significant attention from researchers and pharma companies. Tune in to discover how the dark genome is set to transform the future of medicine.

*PreScouter is at the forefront of AI adoption and is happy to present you this episode courtesy of our AI presenters from Google NotebookLM.